GlassScriptPhysician profile
Olivia Engle
NPI 1245922202
$2,192.26
in general payments reported to CMS, 2019-2025
8 companies · $2,020 in 2025
The $2,020 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $173 · 2025: $2,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137 · Travel and Lodging: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,137.45 |
| Travel and Lodging | $1,054.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,473.73 | 2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Boston Scientific Corporation | $199.13 | 2025 | Lux-Dx Insertable Cardiac Monitor, General - Therapies, Emblem Mri S-Icd |
| Medtronic, INC. | $151.64 | 2024 | Corevalve Evolut R |
| Astrazeneca Pharmaceuticals LP | $106.25 | 2025 | Airsupra |
| Shockwave Medical, INC | $85.22 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $82.43 | 2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.75 | 2025 | Lifevest |
| Abbott Laboratories | $21.11 | 2024 | Cardiomems |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Engle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.